Literature DB >> 7390046

Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine.

W F Caspary, K Meyne.   

Abstract

The effect of equimolar concentrations of chenodeoxycholic (CDCA) and ursodeoxycholic acid (UDCA) on the colonic absorption of water, sodium and oxalate, and on the transmural potential difference was examined in the rat colon by an open perfusion technique. In addition, the ileal absorption of D-glucose, oxalate, water and sodium was measured in the presence and absence of CDCA and UDCA. CDCA reversed the absorption of water and sodium into secretion more effectively than UDCA Oxalate absorption and permeability of the colon measured by the disappearance of D-mannitol were enhanced by CDCA, but to a lesser extent by UDCA. The ileal absorption of water and sodium was nearly abolished by CDCA and inhibited to a lesser extent by UDCA in the presence of D-glucose in the perfusate. At equimolar concentrations, CDCA induced a more marked inhibitory effect on colonic function than UDCA. This quantitative difference may account for the less frequent side-effects of diarrhoea in cholelitholytic treatment with UDCA compared to CDCA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7390046     DOI: 10.1159/000198436

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.

Authors:  Archana S Rao; Banny S Wong; Michael Camilleri; Suwebatu T Odunsi-Shiyanbade; Sanna McKinzie; Michael Ryks; Duane Burton; Paula Carlson; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2010-08-04       Impact factor: 22.682

Review 2.  Recent advances in pharmacological treatment of irritable bowel syndrome.

Authors:  Georgia Lazaraki; Grigoris Chatzimavroudis; Panagiotis Katsinelos
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 3.  Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.

Authors:  Khaled A Jadallah; Susan M Kullab; David S Sanders
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 4.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

5.  Mast cells and histamine contribute to bile acid-stimulated secretion in the mouse colon.

Authors:  C M Gelbmann; C D Schteingart; S M Thompson; A F Hofmann; K E Barrett
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Tauroursodeoxycholic acid is less damaging than taurochenodeoxycholic acid to the gastric and esophageal mucosa.

Authors:  K D Lillemoe; G W Kidder; J W Harmon; T R Gadacz; L F Johnson; R M Bunte; A F Hofmann
Journal:  Dig Dis Sci       Date:  1983-04       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.